Cytisine
- Generic Name
- Cytisine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14N2O
- CAS Number
- 485-35-8
- Unique Ingredient Identifier
- 53S5U404NU
- Background
Cytisine is an alkaloid naturally derived from the Fabaceae family of plants including the genera Laburnum and Cytisus. Recent studies have shown it to be a more effective and significantly more affordable smoking cessation treatment than nicotine replacement therapy. Also known as baptitoxine or sophorine, cytisine has been used as a smoking cessation treat...
- Indication
Indicated for use in smoking cessation.
- Associated Conditions
- Nicotine Craving
- Associated Therapies
- -
A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
- First Posted Date
- 2017-10-06
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Achieve Life Sciences
- Target Recruit Count
- 26
- Registration Number
- NCT03303911
- Locations
- 🇬🇧
Simbec Research Ltd, Cardiff, United Kingdom
A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Achieve Life Sciences
- Target Recruit Count
- 24
- Registration Number
- NCT03268343
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
Cytisine Versus Varenicline for Smoking Cessation
- Conditions
- Interventions
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- University of Auckland, New Zealand
- Target Recruit Count
- 679
- Registration Number
- NCT02957786
- Locations
- 🇳🇿
National Institute for Health Innovation, University of Auckland, Auckland, North Island, New Zealand
Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
- First Posted Date
- 2016-06-13
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Boston Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT02797587
- Locations
- 🇷🇺
First St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation
Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
- First Posted Date
- 2015-10-23
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- University of Auckland, New Zealand
- Target Recruit Count
- 35
- Registration Number
- NCT02585024
- Locations
- 🇳🇿
Soo Hee Jeong, Auckland, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.